• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Coronavirus disease 2019 (COVID-19): A literature review.新型冠状病毒病 2019(COVID-19):文献综述。
J Infect Public Health. 2020 May;13(5):667-673. doi: 10.1016/j.jiph.2020.03.019. Epub 2020 Apr 8.
2
Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak - United States, December 31, 2019-February 4, 2020.2019 年新型冠状病毒疫情的公共卫生初始应对和临时临床指导-美国,2019 年 12 月 31 日至 2020 年 2 月 4 日。
MMWR Morb Mortal Wkly Rep. 2020 Feb 7;69(5):140-146. doi: 10.15585/mmwr.mm6905e1.
3
The First 75 Days of Novel Coronavirus (SARS-CoV-2) Outbreak: Recent Advances, Prevention, and Treatment.新型冠状病毒(SARS-CoV-2)爆发的前 75 天:最新进展、预防和治疗。
Int J Environ Res Public Health. 2020 Mar 30;17(7):2323. doi: 10.3390/ijerph17072323.
4
COVID-19: The outbreak caused by a new coronavirus.新型冠状病毒肺炎:由一种新型冠状病毒引起的疫情。
Bol Med Hosp Infant Mex. 2020;77(2):47-53. doi: 10.24875/BMHIM.20000039.
5
The Novel Coronavirus: A Bird's Eye View.新型冠状病毒:概览
Int J Occup Environ Med. 2020 Apr;11(2):65-71. doi: 10.15171/ijoem.2020.1921. Epub 2020 Feb 5.
6
Occupational health responses to COVID-19: What lessons can we learn from SARS?职业健康对 COVID-19 的应对:我们能从 SARS 中学到什么教训?
J Occup Health. 2020 Jan;62(1):e12128. doi: 10.1002/1348-9585.12128.
7
World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19).世界卫生组织宣布全球紧急状态:对 2019 年新型冠状病毒(COVID-19)的回顾。
Int J Surg. 2020 Apr;76:71-76. doi: 10.1016/j.ijsu.2020.02.034. Epub 2020 Feb 26.
8
COVID-19: a conundrum to decipher.COVID-19:一个待破译的谜。
Eur Rev Med Pharmacol Sci. 2020 May;24(10):5830-5841. doi: 10.26355/eurrev_202005_21378.
9
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges.严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)和 2019 年冠状病毒病(COVID-19):疫情和挑战。
Int J Antimicrob Agents. 2020 Mar;55(3):105924. doi: 10.1016/j.ijantimicag.2020.105924. Epub 2020 Feb 17.
10
Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review.新型冠状病毒病(COVID-19)在早期暴发期间的流行病学、病因、临床表现和诊断、预防和控制:范围综述。
Infect Dis Poverty. 2020 Mar 17;9(1):29. doi: 10.1186/s40249-020-00646-x.

引用本文的文献

1
Multifunctional applications and research advances of low-molecular-weight heparin.低分子量肝素的多功能应用及研究进展
Front Pharmacol. 2025 May 21;16:1585762. doi: 10.3389/fphar.2025.1585762. eCollection 2025.
2
Diagnostic Delay Among Pulmonary Tuberculosis Patients Before, During and After COVID-19 Pandemic in Yichang City, China: A Longitudinal Study Based on Tuberculosis Surveillance Data.中国宜昌市新冠肺炎疫情前后肺结核患者的诊断延迟:一项基于结核病监测数据的纵向研究
J Epidemiol Glob Health. 2025 May 26;15(1):74. doi: 10.1007/s44197-025-00419-5.
3
Antibody Responses to SARS-CoV-2 among Health Care Workers in North-Eastern Tanzania.坦桑尼亚东北部医护人员对新冠病毒的抗体反应
East Afr Health Res J. 2024;8(3):305-314. doi: 10.24248/eahrj.v8i3.799. Epub 2025 Jan 30.
4
Nanotechnology-Based Modern Biosensors for the Detection of SARS-CoV-2 Virus.用于检测新型冠状病毒(SARS-CoV-2)的基于纳米技术的现代生物传感器
Indian J Microbiol. 2025 Mar;65(1):177-188. doi: 10.1007/s12088-024-01404-5. Epub 2024 Oct 7.
5
COVID-19 and Upper Gastrointestinal Bleeding; Etiology, Risk Factors, and Outcomes: A Case-Control Study.新型冠状病毒肺炎与上消化道出血:病因、危险因素及结局的病例对照研究
Middle East J Dig Dis. 2025 Jan;17(1):25-30. doi: 10.34172/mejdd.2025.406. Epub 2025 Jan 31.
6
In Silico and In Vitro Studies of the Approved Antibiotic Ceftaroline Fosamil and Its Metabolites as Inhibitors of SARS-CoV-2 Replication.已批准抗生素头孢洛林酯及其代谢产物作为严重急性呼吸综合征冠状病毒2(SARS-CoV-2)复制抑制剂的计算机模拟和体外研究
Viruses. 2025 Mar 28;17(4):491. doi: 10.3390/v17040491.
7
[Incidence of pulmonary thromboembolism in patients with COVID-19 pneumonia].[新型冠状病毒肺炎患者肺血栓栓塞症的发病率]
Rev Med Inst Mex Seguro Soc. 2025 Jan 3;63(1):e5752. doi: 10.5281/zenodo.14200009.
8
A quantum mechanics-based framework for infectious disease modeling.一种基于量子力学的传染病建模框架。
Sci Rep. 2025 Apr 12;15(1):12602. doi: 10.1038/s41598-025-96817-7.
9
Do physical activity, psychological health, and food group intake change in early pregnancy before and during COVID-19? A secondary analysis of cohort data from the Korea Nurses' Health Study.新冠疫情期间及之前,孕早期的身体活动、心理健康和食物组摄入量会发生变化吗?韩国护士健康研究队列数据的二次分析
Womens Health Nurs. 2025 Mar;31(1):22-33. doi: 10.4069/whn.2025.03.05. Epub 2025 Mar 28.
10
[The sense of coherence among university students: a resource for care in times of pandemicSenso de coerencia nos estudantes universitários: um recurso para o cuidado em tempos de pandemias].[大学生的连贯感:大流行时期的一种关怀资源 大学生的连贯感:大流行时期关怀的一种资源]
Rev Cuid. 2023 Mar 31;13(3):e2435. doi: 10.15649/cuidarte.2435. eCollection 2022 Sep-Dec.

本文引用的文献

1
Decoding the evolution and transmissions of the novel pneumonia coronavirus (SARS-CoV-2 / HCoV-19) using whole genomic data.利用全基因组数据解码新型肺炎冠状病毒(SARS-CoV-2/HCoV-19)的进化和传播。
Zool Res. 2020 May 18;41(3):247-257. doi: 10.24272/j.issn.2095-8137.2020.022.
2
Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines.来自临床批准药物的针对2019新型冠状病毒M蛋白酶的潜在抑制剂。
J Genet Genomics. 2020 Feb 20;47(2):119-121. doi: 10.1016/j.jgg.2020.02.001. Epub 2020 Feb 13.
3
Detection of Covid-19 in Children in Early January 2020 in Wuhan, China.2020年1月初在中国武汉儿童中对新冠病毒病的检测。
N Engl J Med. 2020 Apr 2;382(14):1370-1371. doi: 10.1056/NEJMc2003717. Epub 2020 Mar 12.
4
Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records.九名孕妇感染 COVID-19 的临床特征和宫内垂直传播潜力:病历回顾性研究。
Lancet. 2020 Mar 7;395(10226):809-815. doi: 10.1016/S0140-6736(20)30360-3. Epub 2020 Feb 12.
5
Presumed Asymptomatic Carrier Transmission of COVID-19.新冠病毒无症状感染者的传播。
JAMA. 2020 Apr 14;323(14):1406-1407. doi: 10.1001/jama.2020.2565.
6
Coronavirus covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate.尽管新冠病毒的病死率较低,但新冠病毒造成的死亡人数比非典和中东呼吸综合征的死亡人数总和还要多。
BMJ. 2020 Feb 18;368:m641. doi: 10.1136/bmj.m641.
7
COVID-19: what is next for public health?新冠疫情:公共卫生的下一步走向何方?
Lancet. 2020 Feb 22;395(10224):542-545. doi: 10.1016/S0140-6736(20)30374-3. Epub 2020 Feb 13.
8
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.预防性和治疗性瑞德西韦(GS-5734)治疗中东呼吸综合征冠状病毒感染恒河猴模型。
Proc Natl Acad Sci U S A. 2020 Mar 24;117(12):6771-6776. doi: 10.1073/pnas.1922083117. Epub 2020 Feb 13.
9
The reproductive number of COVID-19 is higher compared to SARS coronavirus.与严重急性呼吸综合征冠状病毒相比,新型冠状病毒肺炎的繁殖数更高。
J Travel Med. 2020 Mar 13;27(2). doi: 10.1093/jtm/taaa021.
10
Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury.临床证据不支持使用皮质类固醇治疗2019新型冠状病毒肺炎肺损伤。
Lancet. 2020 Feb 15;395(10223):473-475. doi: 10.1016/S0140-6736(20)30317-2. Epub 2020 Feb 7.

新型冠状病毒病 2019(COVID-19):文献综述。

Coronavirus disease 2019 (COVID-19): A literature review.

机构信息

Medical Research Unit, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia; Tropical Disease Centre, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia; Department of Microbiology, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia.

Division of Infectious Diseases, AichiCancer Center Hospital, Chikusa-ku Nagoya, Japan.

出版信息

J Infect Public Health. 2020 May;13(5):667-673. doi: 10.1016/j.jiph.2020.03.019. Epub 2020 Apr 8.

DOI:10.1016/j.jiph.2020.03.019
PMID:32340833
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7142680/
Abstract

In early December 2019, an outbreak of coronavirus disease 2019 (COVID-19), caused by a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), occurred in Wuhan City, Hubei Province, China. On January 30, 2020 the World Health Organization declared the outbreak as a Public Health Emergency of International Concern. As of February 14, 2020, 49,053 laboratory-confirmed and 1,381 deaths have been reported globally. Perceived risk of acquiring disease has led many governments to institute a variety of control measures. We conducted a literature review of publicly available information to summarize knowledge about the pathogen and the current epidemic. In this literature review, the causative agent, pathogenesis and immune responses, epidemiology, diagnosis, treatment and management of the disease, control and preventions strategies are all reviewed.

摘要

2019 年 12 月初,一种由新型严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)引起的 2019 年冠状病毒病(COVID-19)疫情在中国湖北省武汉市爆发。2020 年 1 月 30 日,世界卫生组织宣布该疫情为国际关注的突发公共卫生事件。截至 2020 年 2 月 14 日,全球已报告 49053 例实验室确诊病例和 1381 例死亡病例。对疾病感染风险的认识促使许多国家政府采取了各种控制措施。我们对可公开获取的信息进行了文献回顾,以总结有关病原体和当前疫情的知识。在本次文献回顾中,对病原体的病因、发病机制和免疫反应、流行病学、诊断、治疗和管理、控制和预防策略进行了综述。